The the Swiss drugmaker will face off in the obesity area with leaders Novo Nordisk A/S and Indianapolis-based Eli Lilly and ...
Basel, Switzerland and Vacaville, US, 1 October 2024 – Lonza, one of the world’s largest healthcare development and manufacturing organizations, today announced it has completed its acquisition of the ...
The company is set to become the first $1tn drugmaker, but investors see warning signs it has reached ‘peak enthusiasm’ ...
Advancements and Projections in the Global Bacterial and Viral Specimen Collection Market: Insights, Trends, Opportunities, ...
Advancements and Projections in the Global Cholesterol Testing Market: Insights, Trends, Opportunities, and Recent ...